Log in
Enquire now
Euclises Pharmaceuticals

Euclises Pharmaceuticals

A company developing inhibitors for the treatment of cancer

OverviewStructured DataIssuesContributors

Contents

euclises.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Technology
Technology
Biotechnology
Biotechnology
Biopharmaceutical
Biopharmaceutical
Biology
Biology
Location
St. Louis
St. Louis
0
Missouri
Missouri
CEO
‌
Bobby W. Sandage
0
AngelList URL
angel.co/euclises-p...maceuticals
Full Address
4340 Duncan Avenue, Suite 240 Saint Louis, MO 631100
Investors
BioGenerator
BioGenerator
iSelect Fund
iSelect Fund
Missouri Technology Corporation
Missouri Technology Corporation
0
Latest Funding Round Date
January 1, 2004
Latest Funding Type
Series A
Series A
Patents Assigned (Count)
3
Wellfound ID
euclises-pharmaceuticals
Country
United States
United States
0
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Euclises Pharmaceuticals

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.